Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1637-1642

  Kuo, Chin Chi ^a   Wu, Vin Cent ^a   Tsai, Ching Wei ^a   Huang, Kuo How ^a   Wang, So Mong ^a   Li, Bai Chin ^a   Chang, Chin Chen ^a   Lu, Ching Chu ^a   Yang, Wei Shun ^e   Chao, Chia Ter ^a   Tsai, I Chieh ^d   Lai, Chun Fu ^a   Lin, Wei Chou ^a   Wu, Ming Shou ^a   Lin, Yen Hung ^a   Lin, Chien Yu ^b   Chang, Hung Wei ^c   Wang, Wei Jei ^a   Chiang, Wen Chih ^a   Kao, Tze Wah ^a   Chueh, Shih Chieh ^a   Chu, Tzong Shinn ^a   Tsai, Tun Jun ^a   Wu, Kwan Dun ^a   more..

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b EN CHU KONG HOSPITAL   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI HOSPITAL   (Taiwan)

^e Hsin Chu General Hospital   (Taiwan)

Author keywords

Aldosterone to renin ratio (ARR); Primary aldosteronism; Serum potassium to urine potassium clearance (PUKC) ratio

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARAMETERS OF MEASUREMENT AND ANALYSIS; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERUM POTASSIUM TO URINE POTASSIUM CLEARANCE RATIO; URINARY EXCRETION;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79959320474     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.018     Document Type: Article

References (41)

1. Hiramatsu K., Yamada T., Yukimura Y., et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch. Intern. Med. 1981, 141:1589-1593.
2. Fardella C.E., Mosso L., Gomez-Sanchez C., et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J. Clin. Endocrinol. Metab. 2000, 85:1863-1867.
3. Mulatero P., Stowasser M., Loh K.C., et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 2004, 89:1045-1050.
4. Rossi G.P., Bernini G., Caliumi C., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 2006, 48:2293-2300.
5. Funder J.W., Carey R.M., Fardella C., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2008, 93:3266-3281.
6. Gallay B.J., Ahmad S., Xu L., Toivola B., Davidson R.C. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am. J. Kidney Dis. 2001, 37:699-705.
7. Seifarth C., Trenkel S., Schobel H., Hahn E.G., Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin. Endocrinol. 2002, 57:457-465.
8. Fommei E., Ghione S., Ripoli A., et al. The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women. J. Hum. Hypertens. 2009, 23:130-135.
9. Tanabe A., Naruse M., Takagi S., Tsuchiya K., Imaki T., Takano K. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J. Clin. Endocrinol. Metab. 2003, 88:2489-2494.
10. Willenberg H.S., Kolentini C., Quinkler M., et al. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. Eur. J. Clin. Invest. 2009, 39:43-50.
11. Martin R.S., Hayslett J.P. Role of aldosterone in the mechanism of renal potassium adaptation. Pflugers Arch. 1986, 407:76-81.
12. Fallo F., Della Mea P., Sonino N., et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am. J. Hypertens. 2007, 20:855-861.
13. Fallo F., Federspil G., Veglio F., Mulatero P. The metabolic syndrome in primary aldosteronism. Curr. Hypertens. Rep. 2007, 9:106-111.
14. Sechi L.A., Colussi G., Catena C. Metabolic dysfunction in primary aldosteronism. Hypertension 2009, 53:e37-e38.
15. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010, 55:813-818.
16. Lin Y.H., Wang S.M., Wu V.C., et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur. J. Clin. Invest. 2011 Jan 21, [Epub ahead of print].
17. Lin Y.H., Huang K.H., Lee J.K., et al. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J. Renin Angiotensin Aldosterone Syst. 2011, 12:48-53.
18. Yen R.F., Wu V.C., Liu K.L., et al. 131I-6{beta}-Iodomethyl-19-Norcholesterol SPECT/CT for Primary Aldosteronism Patients with Inconclusive Adrenal Venous Sampling and CT Results. J. Nucl. Med. 2009, 50:1631-1637.
19. Wu V.C., Chueh S.C., Chang H.W., et al. Association of Kidney Function with Residual Hypertension after Treatment of Aldosterone-Producing Adenoma. Am. J. Kidney Dis. 2009, 54:665-673.
20. Wu V.C., Chang H.W., Liu K.L., et al. Primary Aldosteronism: Diagnostic Accuracy of the Losartan and Captopril Tests. Am. J. Hypertens. 2009, 22:821-827.
21. Wu V.C., Chueh S.C., Chang H.W., et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM 2008, 101:13-22.
22. Kuo C., Tsai C., Wu V., et al. Aldosteronism Demographics Verification and Evaluation in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J. Renin Angiotensin Aldosterone Syst. 2011 Mar 10, [Epub ahead of print].
23. Chang H.W., Chu T.S., Huang H.Y., et al. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. J. Clin. Endocrinol. Metab. 2007, 92:1863-1870.
24. Wu K.D., Liao T.S., Chen Y.M., et al. Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide. J. Formos. Med. Assoc. 2001, 100:598-603.
25. Wu V.C., Yang S.Y., Lin J.W., et al. Kidney impairment in Primary Aldosteronism. Clin Chim Acta 2011 Feb 21, [Epub ahead of print].
26. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
27. Weinberger M.H., Fineberg N.S. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch. Intern. Med. 1993, 153:2125-2129.
28. Williams J.S., Williams G.H., Raji A., et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J. Hum. Hypertens. 2006, 20:129-136.
29. Tiu S.C., Choi C.H., Shek C.C., et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J. Clin. Endocrinol. Metab. 2005, 90:72-78.
30. Lim P.O., Jung R.T., MacDonald T.M. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity. J. Hum. Hypertens. 2002, 16:153-158.
31. Lim P.O., Struthers A.D., MacDonald T.M. The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?. J. Hypertens. 2002, 20:11-15.
32. Douma S., Petidis K., Doumas M., et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008, 371:1921-1926.
33. Kaplan N.M. Deja vu for primary aldosteronism. Lancet 2008, 371:1890-1891.
34. Cartledge S., Lawson N. Aldosterone and renin measurements. Ann. Clin. Biochem. 2000, 37(Pt 3):262-278.
35. Wu V.C., Kuo C.C., Chang H.W., et al. Diagnosis of primary aldosteronism: Comparison of post-captopril active renin concentration and plasma renin activity. Clin. Chim. Acta 2010, 657-663.
36. Alvarez-Madrazo S., Padmanabhan S., Mayosi B.M., et al. Familial and phenotypic associations of the aldosterone Renin ratio. J. Clin. Endocrinol. Metab. 2009, 94:4324-4333.
37. Tritos N.A. Diagnosis of primary aldosteronism in a patient with an incidentally found adrenal mass. Nat. Clin. Pract. 2007, 3:547-551.
38. Rossi G.P., Sechi L.A., Giacchetti G., Ronconi V., Strazzullo P., Funder J.W. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol. Metab.: TEM 2008, 19:88-90.
39. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J. Mol. Med. (Berlin, Germany) 2008, 86:729-734.
40. Palmer L.G., Frindt G. Aldosterone and potassium secretion by the cortical collecting duct. Kidney Int. 2000, 57:1324-1328.
41. Rossi G.P., Belfiore A., Bernini G., et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J. Clin. Endocrinol. Metab. 2008, 93:2566-2571.